Skip to Content
Merck
  • Transcatheter embolisation of type 1 endoleaks after endovascular aortic aneurysm repair with Onyx: when no other treatment option is feasible.

Transcatheter embolisation of type 1 endoleaks after endovascular aortic aneurysm repair with Onyx: when no other treatment option is feasible.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery (2013-01-02)
J-Y Chun, R Morgan
ABSTRACT

Type 1 endoleaks following endovascular aortic aneurysm repair are associated with poor outcomes and re-intervention is recommended as soon as possible after diagnosis. When standard endovascular or surgical treatment options are unsuitable due to severe co-morbidity or adverse anatomic factors, patients can be treated by transcatheter embolisation of the endoleak itself. We describe six such patients with proximal and distal type 1 endoleaks, who have been successfully treated by transcatheter embolisation with Onyx. The embolisation technique, advantages of using this relatively novel liquid embolic agent and potential pitfalls are discussed.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Tantalum, powder, 60-100 mesh, 99.9%
Sigma-Aldrich
Tantalum, powder, −325 mesh, 99.9% trace metals basis
Sigma-Aldrich
Tantalum, foil, thickness 0.05 mm, ≥99.9% trace metals basis
Sigma-Aldrich
Tantalum, foil, thickness 1.0 mm, ≥99.9% trace metals basis
Sigma-Aldrich
Tantalum, foil, thickness 0.25 mm, ≥99.9% trace metals basis
Sigma-Aldrich
Tantalum, foil, thickness 0.5 mm, ≥99.9% trace metals basis
Sigma-Aldrich
Tantalum, wire, diam. 1.0 mm, ≥99.9% trace metals basis
Sigma-Aldrich
Tantalum
Sigma-Aldrich
Tantalum, foil, thickness 0.025 mm, ≥99.9% trace metals basis